Axitinib (AG-013736) in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma
Clinical trial NCT01558661 · COMPLETED
Trial details
- NCT number
- NCT01558661
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2016-08-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.